Novavax doubles aims for 2 billion Covid-19 vaccine doses with expanded India deal | World News - Hindustan Times
close_game
close_game

Novavax doubles aims for 2 billion Covid-19 vaccine doses with expanded India deal

ByReuters | Posted by Karan Manral
Sep 16, 2020 07:41 AM IST

In August, the US drugmaker had signed a deal with the Serum Institute of India, the world’s largest producer of vaccines, to produce a minimum of one billion doses of its vaccine candidate.

U.S. drug developer Novavax Inc said on Tuesday it was doubling its potential Covid-19 vaccine manufacturing capacity to two billion doses annually under an agreement with Serum Institute of India, sending its shares up about 7%.

FILE PHOTO: Small bottles labelled with a "Vaccine COVID-19" sticker and a medical syringe are seen in this illustration (REUTERS/Dado Ruvic/Illustration)
FILE PHOTO: Small bottles labelled with a "Vaccine COVID-19" sticker and a medical syringe are seen in this illustration (REUTERS/Dado Ruvic/Illustration)

In August, Novavax signed a deal with Serum Institute, the world’s largest producer of vaccines, to produce a minimum of one billion doses of its vaccine candidate, when approved, for low- and middle-income countries and India.

Hindustan Times - your fastest source for breaking news! Read now.

As part of the expanded agreement, Serum Institute will also manufacture the antigen component of the vaccine, dubbed NVX‑CoV2373, which Novavax said will bring its manufacturing capacity to over two billion doses by mid-2021.

Novavax’s vaccine is currently in mid-stage trials after an early-stage study showed it produced high levels of antibodies against the novel coronavirus. The company plans to begin late-stage trials in the third quarter.

Last month, Novavax said it will supply 60 million doses of its coronavirus vaccine candidate to the UK beginning as early as the first quarter of 2021.

The company is also preparing to deliver 100 million doses to the United States by January after it was awarded $1.6 billion for its potential vaccine, and has also signed supply agreements with Canada and Japan.

Other drugmakers such as Pfizer Inc and Moderna Inc have already begun large late-stage studies of their experimental vaccines.

Unlock a world of Benefits with HT! From insightful newsletters to real-time news alerts and a personalized news feed – it's all here, just a click away! - Login Now!

Get Latest World News along with Latest News from India at Hindustan Times.
SHARE THIS ARTICLE ON
Share this article
SHARE
Story Saved
Live Score
OPEN APP
Saved Articles
Following
My Reads
Sign out
New Delhi 0C
Friday, March 29, 2024
Start 14 Days Free Trial Subscribe Now
Follow Us On